Business Wire

Onera Will Showcase Its Onera hPSG® Solution at the SLEEP 2026 Conference June 14-17, 2026 in Baltimore, MD, USA.

11.6.2026 15:00:00 CEST | Business Wire | Press Release

Share

Onera Health, a leader in transforming sleep medicine, announces that its end-to-end home polysomnography solution, the Onera hPSG® solution, will be prominently featured in multiple scientific presentations at the forthcoming SLEEP 2026 conference. The medtech company will showcase this innovative solution at booth #600 during the largest annual sleep medicine conference, which brings together leading experts and innovators in the field. Furthermore, in anticipation of new CPT codes, Onera Health will host an educational symposium on Scaling PSG for the Next Decade: Expanding Utilization of High-Complexity Home Testingon Monday, June 15.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260611302332/en/

Onera hPSG® – Bringing PSG Home.

“We are excited to see our Onera hPSG® solution highlighted at this important meeting in three different presentations and an educational seminar. Onera hPSG® is positioned to be an integral part of the evolving field of sleep medicine enabling PSG, the gold standard of sleep testing, to be performed in the patient’s home, increasing access and convenience while providing equivalent diagnostic insights,” states Ruben de Francisco, Founder and CEO of Onera Health.

"Onera hPSG® - Bringing PSG Home"

At the Onera sponsored educational seminar titled Scaling PSG for the Next Decade: Expanding Utilization of High-Complexity Home Testing, experts from leading institutions will present and discuss validation results, insights from real-world implementation, and the clinical and practice implications of home PSG testing. Presentations will include:

  • Mild or Missed? Women Deserve Better Sleep Diagnostics presented by Audrey Wells, MD, Chief Medical Officer at SLIIIP.com.
  • Bringing Comprehensive Sleep Diagnostics to the Home: Real World Experience from Kaiser Permanente”, presented by Anupamjeet Sekhon, MD, Kaiser Permanente Fontana Medical Center.

“Home polysomnography addresses significant access challenges for patients who would benefit from PSG testing. These challenges are caused by the shortage of in-laboratory beds, technicians, and sleep physicians and have led to escalating costs and delayed diagnosis and treatment for many patients suffering from sleep disorders. We are confident this symposium will present valuable information and spark insightful conversations amongst the panelists and participants regarding how hPSG can enhance patient care pathways and be a potential solution to unmet needs in sleep diagnostics and care, explains de Francisco.

Clinical data related to the Onera hPSG® solution will also be presented in three poster presentations this year. Details of the presentations are as follows:

A Real-World Analysis of Patient-Applied, Home Polysomnography Use Across US and European Settings 
Dimitrov T, Stockhoff M, Coughlin S, Schneider H, Velten N 
Poster Session P-17 on Monday, June 15, 2026 [ID 1187, Board 394]

Home vs. Lab Polysomnography with a Patch-based System: Longer, More Efficient Sleep at Home Without Respiratory Trade-offs 
Schobel C, Viniol C, Galetke W, Woehrle H, Nilius G, Randerath W, Schneider H 
Poster Session P-40 on Tuesday, June 16, 2026 [ID 1213, Board 403]

Real-World Validation of Automated Scoring of Home Polysomnography Data 
Zimeo Morais G, Meulenbrugge E, Dimitrov T, Honer N, Schneider H 
Poster Session P-41 on Tuesday, June 16, 2026 [ID 1455, Board 449]

For more information on the educational event and presentations, please review the SLEEP 2026 agenda at SLEEP Annual Meeting | Program.

About Onera Health

Onera Health is leading the way in transforming sleep medicine by delivering the gold standard of sleep testing, polysomnography (PSG), directly to where the patient sleeps comfortably, in their own home.

The Onera hPSG® solution is expanding access to comprehensive sleep diagnostics for millions of people who remain undiagnosed or undertreated by breaking down long-standing barriers such as limited lab capacity, geographic access, and operational complexity. Through its integrated diagnostic technology, clinical services, and digital platform, Onera hPSG® empowers clinicians with comprehensive, actionable insights while helping healthcare systems deliver more efficient, scalable care.

With commercial operations in the United States and Europe, Onera Health is at the forefront of advancing global sleep health and transforming how sleep disorders are detected, identified, and managed. For more information, visit onerahealth.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20260611302332/en/

Contacts

For additional information or media inquiries, please contact:
Swea Ann Hagenhoff
Sr. Branding and Communications Specialist
Onera Health
media@onerahealth.com

(c) 2024 Business Wire, Inc., All rights reserved.

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Mobix Labs Signs Definitive Agreement to Acquire Vision Aerial, Accelerating Global Drone Platform for National Security and Aerial Intelligence24.7.2026 13:00:00 CEST | Press Release

Mobix Labs, Inc. (Nasdaq: MOBX) today announced that it has signed a definitive agreement to acquire Vision Aerial, Inc., a U.S.-based designer and manufacturer of American-built, National Defense Authorization Act (NDAA)-compliant unmanned aerial systems. The definitive agreement moves the transaction beyond the previously announced letter of intent and represents a major step toward closing an acquisition that would expand Mobix Labs into one of the world’s most important technology growth markets: secure drones, autonomous aerial systems and aerial intelligence for national security, critical infrastructure, energy, public safety, industrial inspection and government operations. Vision Aerial’s customers and end-users include the U.S. Air Force, U.S. Navy, government agencies, energy and utility operators, research institutions and other organizations requiring performance, reliability and trusted supply chains. Its drones support national security and public-safety operations, sear

Enhertu ® Plus Pertuzumab Recommended for Approval in the EU by CHMP as First-Line Treatment for Patients with HER2 Positive Metastatic Breast Cancer24.7.2026 13:00:00 CEST | Press Release

Enhertu® (trastuzumab deruxtecan) in combination with pertuzumab has been recommended for approval in the European Union (EU) for the first-line treatment of adult patients with unresectable or metastatic HER2 positive (immunohistochemistry [IHC] 3+ or in-situ hybridization [ISH]+) breast cancer. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from theDESTINY-Breast09 phase 3 trialpresented at the 2025 American Society of Clinical Oncology Annual Meeting and subsequently published in The New England Journal of Medicine. The recommendation will now be reviewed by the European Commission, which has the authority to grant marketing authorizations for medicines in the EU. In DESTI

SLB Announces Second-Quarter 2026 Results24.7.2026 12:50:00 CEST | Press Release

SLB (NYSE: SLB) today announced results for the second-quarter 2026. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260722694386/en/ The exterior of the SLB headquarters in Houston, Texas. Second-Quarter Results(Stated in millions, except per share amounts)Three Months EndedChangeJun. 30, 2026Mar. 31, 2026Jun. 30, 2025SequentialYear-on-yearRevenue $8,972 $8,721 $8,546 3% 5% Income before taxes - GAAP basis $1,018 $956 $1,285 6% -21% Income before taxes margin - GAAP basis 11.3% 11.0% 15.0% 38 bps -369 bps Net income attributable to SLB - GAAP basis $786 $752 $1,014 5% -22% Diluted EPS - GAAP basis $0.52 $0.50 $0.74 4% -30% Adjusted EBITDA* $1,899 $1,773 $2,051 7% -7% Adjusted EBITDA margin* 21.2% 20.3% 24.0% 83 bps -284 bps Pretax segment operating income* $1,404 $1,321 $1,584 6% -11% Pretax segment operating margin* 15.6% 15.2% 18.5% 49 bps -289 bps Net income attributable to SLB, excluding charges & credits* $833 $783 $1,0

NIQ Expands GenAI Capabilities Across gfknewron, Turning Trusted Intelligence into Decisions Faster24.7.2026 12:30:00 CEST | Press Release

NIQ (NYSE: NIQ), a leader in consumer intelligence, today announced the expansion of AI-powered Smart Insights across its gfknewron® platform. By bringing together markets and categories into a single view, gfknewron enables businesses to transform complex market, consumer and supply chain data into clear, actionable intelligence quickly. The latest enhancements help users identify trends, opportunities and performance drivers more quickly, reducing the time required to analyze large datasets and accelerating confident decision-making across teams. As brands and retailers face growing pressure to respond quickly to changing consumer behavior and market dynamics, the ability to unlock meaningful insights from increasingly rich datasets has become a significant competitive advantage. As AI is only as effective as the intelligence behind it, Smart Insights helps businesses realize the full value of NIQ's trusted market intelligence by automatically surfacing the trends, opportunities and

Thales to Strengthen Romania’s Airspace Protection With Twelve Ground Master 200 MM/A Radars24.7.2026 10:05:00 CEST | Press Release

In a context of growing collaboration between European nations to bolster collective security, the Romanian General Directorate for Armaments has just signed a landmark agreement with France’s Direction Générale de l’Armement (DGA) to acquire twelve Thales Ground Master 200 Multi-Mission All-in-one (GM200 MM/A) radars. This government-to-government agreement, funded under the European Union’s SAFE programme, underlines the high level of partnership between France and Romania. The first delivery is expected in 2027. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260724603527/en/ The Romanian General Directorate for Armaments and the French Direction Générale de l’Armement (DGA – the French defence procurement agency) have signed an agreement to supply twelve Thales GM200 Multi-Mission All-in-one (GM200MM/A) radars to protect the Romanian airspace. The GM200 MM/A is a combat-proven medium-range 4D AESA radar, already deployed

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye